154
OnKure Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
106
FY23:
33.8
FY24:
113
FY25:
60.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.29
FY22:
1.83
FY23:
1.97
FY24:
1.90
FY25:
1.28
Total assets
Change from FY21 to FY25
millions USD
FY21:
154
FY22:
108
FY23:
35.7
FY24:
115
FY25:
62.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.20
FY22:
7.12
FY23:
7.29
FY24:
10.5
FY25:
5.92
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.61
FY22:
1.09
FY23:
0.47
FY24:
0.55
FY25:
0.01
(positive)
Change from FY21 to FY25
millions USD
FY21:
147
FY22:
100.0
FY23:
−102
FY24:
104
FY25:
56.2
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
154
FY22:
108
FY23:
–
FY24:
115
FY25:
62.1
All amounts in millions USD